Hirasawa v. Bayer

Court

District Court, E.D. New York (E.D.N.Y)
Official Court Website →

Assigned judge

Joan M. Azrack · 2,199 cases in index

Docket number

2:19-cv-02292

Nature of suit

367 Health care / pharm
Injury from a drug, medical device, or health-care product — often grouped into mass-tort litigation.

Jurisdiction

Diversity of citizenship

Date filed

04/18/2019

Date terminated

04/30/2019

9,368 Product Liability cases in this court are indexed here.

Parties

• plaintiff · Hirasawa · 2 cases
• defendant · Bayer · 232 cases

About Product Liability Lawsuits

Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.

Frequently Asked Questions

What is Hirasawa v. Bayer?

Hirasawa v. Bayer is a federal product liability lawsuit filed on 04/18/2019 in the District Court, E.D. New York. The case was terminated on 04/30/2019. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.

What type of case is this?

It is classified as “Product Liability” under the federal nature-of-suit system. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.

What court is the case in?

The case is in the District Court, E.D. New York, docket number 2:19-cv-02292.

When was the case filed?

Hirasawa v. Bayer was filed on 04/18/2019. It was terminated on 04/30/2019.